Your browser doesn't support javascript.
loading
Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCß1.
Melnyk, James E; Steri, Veronica; Nguyen, Hao G; Hwang, Y Christina; Gordan, John D; Hann, Byron; Feng, Felix Y; Shokat, Kevan M.
Afiliação
  • Melnyk JE; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, 94158, USA.
  • Steri V; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, USA.
  • Nguyen HG; Preclinical Therapeutics Core, University of California San Francisco, San Francisco, CA, 94158, USA.
  • Hwang YC; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, USA.
  • Gordan JD; Department of Urology, University of California, San Francisco, San Francisco, CA, 94143, USA.
  • Hann B; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, USA.
  • Feng FY; Department of Medicine and Division of Hematology/Oncology, University of California, San Francisco, San Francisco, CA, 94158, USA.
  • Shokat KM; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, 94158, USA.
Oncogene ; 41(11): 1536-1549, 2022 03.
Article em En | MEDLINE | ID: mdl-35087237

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias de Próstata Resistentes à Castração / Proteína Quinase C beta Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias de Próstata Resistentes à Castração / Proteína Quinase C beta Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article